Diagnostics & Research

OPKO Health Among Top Players in Secondary Hyperparathyroidism Treatment Industry with 2031 Growth Drivers

☀️Trending News OPKO ($NASDAQ:OPK) Health is one of the top players in the secondary hyperparathyroidism (SHPT) treatment industry with 2031 [...]

By |December 20, 2023|Categories: Diagnostics & Research, Profitability|Tags: , , |0 Comments

Twist Bioscience Intrinsic Value Calculator – Exploring if Twist Bioscience is a Smart Investment or a Value Trap

☀️Trending News Twist Bioscience ($NASDAQ:TWST) is a biotechnology company that specializes in the synthesis of DNA, RNA, and other molecules [...]

TWIST BIOSCIENCE Reports 16.8% Year-Over-Year Increase in Total Revenue for Fourth Quarter of FY2023

☀️Earnings Overview For the fourth quarter of fiscal year 2023, TWIST BIOSCIENCE ($NASDAQ:TWST) reported total revenue of USD 67.0 million, [...]

IQVIA Holdings Leads Healthcare Contract Research Outsourcing Market Boom Worldwide

🌥️Trending News IQVIA ($NYSE:IQV) Holdings has been a major player in the growing global healthcare contract research outsourcing (CRO) market. [...]

By |December 19, 2023|Categories: Diagnostics & Research, Market Forecasts|Tags: , , |0 Comments

Mettler-toledo International Stock Fair Value – METTLER-TOLEDO INTERNATIONAL Reports Third Quarter Financial Results for Fiscal Year 2023

🌥️Earnings Overview On November 9, 2023, METTLER-TOLEDO INTERNATIONAL ($NYSE:MTD) reported financial results for the third quarter of fiscal year 2023, [...]

GUARDANT HEALTH Reports 21.8% Year-Over-Year Revenue Increase in Q3 of FY2023, Net Income Decreases -162.0 Million

☀️Earnings Overview For the third quarter of FY2023 ending September 30 2023, GUARDANT HEALTH ($NASDAQ:GH) reported total revenue of USD [...]

Personalis Stock Fair Value – PERSONALIS Reports Record-Breaking FY2023 Q3 Earnings Results for Period Ending November 7 2023

🌥️Earnings Overview On November 7 2023, PERSONALIS ($NASDAQ:PSNL) reported its Q3 FY2023 earnings results for the period ending September 30 [...]

Go to Top